Controlled release strategies for modulating immune responses to promote tissue regeneration

Journal of Controlled Release

Volumn 219, Issue , 2015, Pages 155-166

  Dumont, Courtney M ^a   Park, Jonghyuck ^a   Shea, Lonnie D ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Biomaterials; Cell transplantation; Gene delivery; Immune modulation; Immune system; Nanoparticles; Stem cells; T cells; Tissue engineering

Indexed keywords

BIOMATERIALS; CELL ENGINEERING; CELLS; CYTOLOGY; DISEASE CONTROL; GENE THERAPY; GENE TRANSFER; GENES; IMMUNE SYSTEM; MODULATION; NANOPARTICLES; STEM CELLS; T-CELLS; TISSUE; TISSUE ENGINEERING;

ADAPTIVE IMMUNE RESPONSE; ANTI-INFLAMMATORIES; CELL TRANSPLANTATION; DEGENERATIVE DISEASE; GENE DELIVERY; IMMUNE MODULATION; IMMUNOSUPPRESSIVE AGENT; REGENERATIVE MEDICINE;

TISSUE REGENERATION;

ANTIINFLAMMATORY AGENT; BIOMATERIAL; CYTOKINE; IMMUNOSUPPRESSIVE AGENT; NANOPARTICLE; RECOMBINANT PROTEIN; DELAYED RELEASE FORMULATION;

ADAPTIVE IMMUNITY; ARTICLE; AUTOIMMUNITY; CELL TRANSPLANTATION; CONTROLLED DRUG RELEASE; DRUG DELIVERY SYSTEM; GENE THERAPY; GENE VECTOR; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; INNATE IMMUNITY; LEUKOCYTE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REGENERATIVE MEDICINE; SYSTEMIC THERAPY; TISSUE ENGINEERING; TISSUE INJURY; TISSUE REGENERATION; ADMINISTRATION AND DOSAGE; ANIMAL; DELAYED RELEASE FORMULATION; IMMUNOLOGY; REGENERATION;

ANIMALS; DELAYED-ACTION PREPARATIONS; HUMANS; IMMUNOMODULATION; REGENERATION; TISSUE ENGINEERING;

EID: 84947492634     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2015.08.014     Document Type: Article

References (179)

1. E.A. Finkelstein, T.R. Miller, and Associates The Incidence and Economic Burden of Injuries in the United States 1st ed. 2006 Oxford University USA
2. R.M. Boehler, J.G. Graham, and L.D. Shea Tissue engineering tools for modulation of the immune response Biotechniques 51 2011 239 240 (242, 244 passim)
3. T.B. Jones Lymphocytes and autoimmunity after spinal cord injury Exp. Neurol. 258 2014 78 90
4. S. Franz, S. Rammelt, D. Scharnweber, and J.C. Simon Immune responses to implants - a review of the implications for the design of immunomodulatory biomaterials Biomaterials 32 2011 6692 6709
5. K. Schwach-Abdellaoui, N. Vivien-Castioni, and R. Gurny Local delivery of antimicrobial agents for the treatment of periodontal diseases Eur. J. Pharm. Biopharm. 50 2000 83 99
6. R.F. Gibly, J.G. Graham, X. Luo, W.L. Lowe Jr., B.J. Hering, and L.D. Shea Advancing islet transplantation: from engraftment to the immune response Diabetologia 54 2011 2494 2505
7. A.S. Chong, and M.L. Alegre The impact of infection and tissue damage in solid-organ transplantation Nat. Rev. Immunol. 12 2012 459 471
8. D.R. Goldstein, B.M. Tesar, S. Akira, and F.G. Lakkis Critical role of the Toll-like receptor signal adaptor protein MyD88 in acute allograft rejection J. Clin. Invest. 111 2003 1571 1578
9. Y. Uchida, B. Ke, M.C. Freitas, H. Yagita, H. Akiba, R.W. Busuttil, N. Najafian, and J.W. Kupiec-Weglinski T-cell immunoglobulin mucin-3 determines severity of liver ischemia/reperfusion injury in mice in a TLR4-dependent manner Gastroenterology 139 2010 2195 2206
10. S. Fiorenza, T.J. Kenna, I. Comerford, S. McColl, R.J. Steptoe, G.R. Leggatt, and I.H. Frazer A combination of local inflammation and central memory T cells potentiates immunotherapy in the skin J. Immunol. 189 2012 5622 5631
11. L. Shen, Y. Jin, G.J. Freeman, A.H. Sharpe, and M.R. Dana The function of donor versus recipient programmed death-ligand 1 in corneal allograft survival J. Immunol. 179 2007 3672 3679
12. S.P. Cobbold, E. Adams, L. Graca, S. Daley, S. Yates, A. Paterson, N.J. Robertson, K.F. Nolan, P.J. Fairchild, and H. Waldmann Immune privilege induced by regulatory T cells in transplantation tolerance Immunol. Rev. 213 2006 239 255
13. H. Nakajima, K. Uchida, A.R. Guerrero, S. Watanabe, D. Sugita, N. Takeura, A. Yoshida, G. Long, K.T. Wright, W.E. Johnson, and H. Baba Transplantation of mesenchymal stem cells promotes an alternative pathway of macrophage activation and functional recovery after spinal cord injury J. Neurotrauma 29 2012 1614 1625
14. J. Park, E. Lim, S. Back, H. Na, Y. Park, and K. Sun Nerve regeneration following spinal cord injury using matrix metalloproteinase-sensitive, hyaluronic acid-based biomimetic hydrogel scaffold containing brain-derived neurotrophic factor J. Biomed. Mater. Res. A 93 2010 1091 1099
15. H. Blomeier, X. Zhang, C. Rives, M. Brissova, E. Hughes, M. Baker, A.C. Powers, D.B. Kaufman, L.D. Shea, and W.L. Lowe Jr. Polymer scaffolds as synthetic microenvironments for extrahepatic islet transplantation Transplantation 82 2006 452 459
16. R.F. Gibly, X. Zhang, M.L. Graham, B.J. Hering, D.B. Kaufman, W.L. Lowe Jr., and L.D. Shea Extrahepatic islet transplantation with microporous polymer scaffolds in syngeneic mouse and allogeneic porcine models Biomaterials 32 2011 9677 9684
17. R.A. Underwood, M.L. Usui, G. Zhao, K.D. Hauch, M.M. Takeno, B.D. Ratner, A.J. Marshall, X. Shi, J.E. Olerud, and P. Fleckman Quantifying the effect of pore size and surface treatment on epidermal incorporation into percutaneously implanted sphere-templated porous biomaterials in mice J. Biomed. Mater. Res. A 98 2011 499 508
18. L.R. Madden, D.J. Mortisen, E.M. Sussman, S.K. Dupras, J.A. Fugate, J.L. Cuy, K.D. Hauch, M.A. Laflamme, C.E. Murry, and B.D. Ratner Proangiogenic scaffolds as functional templates for cardiac tissue engineering Proc. Natl. Acad. Sci. U. S. A. 107 2010 15211 15216
19. G.C. Gurtner, S. Werner, Y. Barrandon, and M.T. Longaker Wound repair and regeneration Nature 453 2008 314 321
20. R.F. Diegelmann, and M.C. Evans Wound healing: an overview of acute, fibrotic and delayed healing Front. Biosci. 9 2004 283 289
21. J.M. Anderson, A. Rodriguez, and D.T. Chang Foreign body reaction to biomaterials Semin. Immunol. 20 2008 86 100
22. A. Sano, T. Hojo, M. Maeda, and K. Fujioka Protein release from collagen matrices Adv. Drug Deliv. Rev. 31 1998 247 266
23. K.P. Vercruysse, and G.D. Prestwich Hyaluronate derivatives in drug delivery Crit. Rev. Ther. Drug Carrier Syst. 15 1998 513 555
24. J.P. Draye, B. Delaey, A. Van de Voorde, A. Van Den Bulcke, B. De Reu, and E. Schacht In vitro and in vivo biocompatibility of dextran dialdehyde cross-linked gelatin hydrogel films Biomaterials 19 1998 1677 1687
25. K.A. Athanasiou, G.G. Niederauer, and C.M. Agrawal Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/polyglycolic acid copolymers Biomaterials 17 1996 93 102
26. C. Espadas-Torre, and M.E. Meyerhoff Thrombogenic properties of untreated and poly(ethylene oxide)-modified polymeric matrices useful for preparing intraarterial ion-selective electrodes Anal. Chem. 67 1995 3108 3114
27. A. Lejardi, R. Hernandez, M. Criado, J.I. Santos, A. Etxeberria, J.R. Sarasua, and C. Mijangos Novel hydrogels of chitosan and poly(vinyl alcohol)-g-glycolic acid copolymer with enhanced rheological properties Carbohydr. Polym. 103 2014 267 273
28. A. Hezi-Yamit, C. Sullivan, J. Wong, L. David, M. Chen, P. Cheng, D. Shumaker, J.N. Wilcox, and K. Udipi Impact of polymer hydrophilicity on biocompatibility: implication for DES polymer design J. Biomed. Mater. Res. A 90 2009 133 141
29. J.A. Jones, D.T. Chang, H. Meyerson, E. Colton, I.K. Kwon, T. Matsuda, and J.M. Anderson Proteomic analysis and quantification of cytokines and chemokines from biomaterial surface-adherent macrophages and foreign body giant cells J. Biomed. Mater. Res. A 83 2007 585 596
30. O. Veiseh, J.C. Doloff, M. Ma, A.J. Vegas, H.H. Tam, A.R. Bader, J. Li, E. Langan, J. Wyckoff, W.S. Loo, S. Jhunjhunwala, A. Chiu, S. Siebert, K. Tang, J. Hollister-Lock, S. Aresta-Dasilva, M. Bochenek, J. Mendoza-Elias, Y. Wang, M. Qi, D.M. Lavin, M. Chen, N. Dholakia, R. Thakrar, I. Lacik, G.C. Weir, J. Oberholzer, D.L. Greiner, R. Langer, and D.G. Anderson Size- and shape-dependent foreign body immune response to materials implanted in rodents and non-human primates Nat. Mater. 14 2015 643 651
31. E. Saino, M.L. Focarete, C. Gualandi, E. Emanuele, A.I. Cornaglia, M. Imbriani, and L. Visai Effect of electrospun fiber diameter and alignment on macrophage activation and secretion of proinflammatory cytokines and chemokines Biomacromolecules 12 2011 1900 1911
32. H. Cao, K. McHugh, S.Y. Chew, and J.M. Anderson The topographical effect of electrospun nanofibrous scaffolds on the in vivo and in vitro foreign body reaction J. Biomed. Mater. Res. A 93 2010 1151 1159
33. A.K. Blakney, M.D. Swartzlander, and S.J. Bryant The effects of substrate stiffness on the in vitro activation of macrophages and in vivo host response to poly(ethylene glycol)-based hydrogels J. Biomed. Mater. Res. A 100 2012 1375 1386
34. K.A. Barth, J.D. Waterfield, and D.M. Brunette The effect of surface roughness on RAW 264.7 macrophage phenotype J. Biomed. Mater. Res. A 101 2013 2679 2688
35. S. Lee, J. Choi, S. Shin, Y.M. Im, J. Song, S.S. Kang, T.H. Nam, T.J. Webster, S.H. Kim, and D. Khang Analysis on migration and activation of live macrophages on transparent flat and nanostructured titanium Acta Biomater. 7 2011 2337 2344
36. J.M. Zuidema, M.C. Hyzinski-Garcia, K. Van Vlasselaer, N.W. Zaccor, G.E. Plopper, A.A. Mongin, and R.J. Gilbert Enhanced GLT-1 mediated glutamate uptake and migration of primary astrocytes directed by fibronectin-coated electrospun poly-l-lactic acid fibers Biomaterials 35 2014 1439 1449
37. E. Beurel, L.E. Harrington, W. Buchser, V. Lemmon, and R.S. Jope Astrocytes modulate the polarization of CD4 + T cells to Th1 cells PLoS One 9 2014 e86257
38. P.S. Hume, and K.S. Anseth Inducing local T cell apoptosis with anti-Fas-functionalized polymeric coatings fabricated via surface-initiated photopolymerizations Biomaterials 31 2010 3166 3174
39. L.J. Noble, F. Donovan, T. Igarashi, S. Goussev, and Z. Werb Matrix metalloproteinases limit functional recovery after spinal cord injury by modulation of early vascular events J. Neurosci. 22 2002 7526 7535
40. R.E. Whitmire, D.S. Wilson, A. Singh, M.E. Levenston, N. Murthy, and A.J. Garcia Self-assembling nanoparticles for intra-articular delivery of anti-inflammatory proteins Biomaterials 33 2012 7665 7675
41. C.A. Cuff, J.A. Martiney, J.W. Berman, and C.F. Brosnan Differential effects of transforming growth factor-beta 1 on interleukin-1-induced cellular inflammation and vascular permeability in the rabbit retina J. Neuroimmunol. 70 1996 21 28
42. C.A. Lazarski, J. Ford, S.D. Katzman, A.F. Rosenberg, and D.J. Fowell IL-4 attenuates Th1-associated chemokine expression and Th1 trafficking to inflamed tissues and limits pathogen clearance PLoS One 8 2013 e71949
43. R.M. Locksley Asthma and allergic inflammation Cell 140 2010 777 783
44. F.O. Martinez, A. Sica, A. Mantovani, and M. Locati Macrophage activation and polarization Front. Biosci. 13 2008 453 461
45. N. Mokarram, A. Merchant, V. Mukhatyar, G. Patel, and R.V. Bellamkonda Effect of modulating macrophage phenotype on peripheral nerve repair Biomaterials 33 2012 8793 8801
46. A.J. Rao, C. Nich, L.S. Dhulipala, E. Gibon, R. Valladares, S. Zwingenberger, R.L. Smith, and S.B. Goodman Local effect of IL-4 delivery on polyethylene particle induced osteolysis in the murine calvarium J. Biomed. Mater. Res. A 101 2013 1926 1934
47. C.L. Wu, L.Y. Lin, J.S. Yang, M.C. Chan, and C.M. Hsueh Attenuation of lipopolysaccharide-induced acute lung injury by treatment with IL-10 Respirology 14 2009 511 521
48. D. Projahn, S. Simsekyilmaz, S. Singh, I. Kanzler, B.K. Kramp, M. Langer, A. Burlacu, J. Bernhagen, D. Klee, A. Zernecke, T.M. Hackeng, J. Groll, C. Weber, E.A. Liehn, and R.R. Koenen Controlled intramyocardial release of engineered chemokines by biodegradable hydrogels as a treatment approach of myocardial infarction J. Cell. Mol. Med. 18 2014 790 800
49. J. Grommes, J.E. Alard, M. Drechsler, S. Wantha, M. Morgelin, W.M. Kuebler, M. Jacobs, P. von Hundelshausen, P. Markart, M. Wygrecka, K.T. Preissner, T.M. Hackeng, R.R. Koenen, C. Weber, and O. Soehnlein Disruption of platelet-derived chemokine heteromers prevents neutrophil extravasation in acute lung injury Am. J. Respir. Crit. Care Med. 185 2012 628 636
50. G. O'Boyle, C.R. Fox, H.R. Walden, J.D. Willet, E.R. Mavin, D.W. Hine, J.M. Palmer, C.E. Barker, C.A. Lamb, S. Ali, and J.A. Kirby Chemokine receptor CXCR3 agonist prevents human T-cell migration in a humanized model of arthritic inflammation Proc. Natl. Acad. Sci. U. S. A. 109 2012 4598 4603
51. S. Jhunjhunwala, G. Raimondi, A.J. Glowacki, S.J. Hall, D. Maskarinec, S.H. Thorne, A.W. Thomson, and S.R. Little Bioinspired controlled release of CCL22 recruits regulatory T cells in vivo Adv. Mater. 24 2012 4735 4738
52. A.W. Mailloux, and M.R. Young NK-dependent increases in CCL22 secretion selectively recruits regulatory T cells to the tumor microenvironment J. Immunol. 182 2009 2753 2765
53. J. Montane, L. Bischoff, G. Soukhatcheva, D.L. Dai, G. Hardenberg, M.K. Levings, P.C. Orban, T.J. Kieffer, R. Tan, and C.B. Verchere Prevention of murine autoimmune diabetes by CCL22-mediated Treg recruitment to the pancreatic islets J. Clin. Invest. 121 2011 3024 3028
54. X.J. Qin, H.Z. Shi, J.M. Deng, Q.L. Liang, J. Jiang, and Z.J. Ye CCL22 recruits CD4-positive CD25-positive regulatory T cells into malignant pleural effusion Clin. Cancer Res. 15 2009 2231 2237
55. J. Chung, M.H. Kim, Y.J. Yoon, K.H. Kim, S.R. Park, and B.H. Choi Effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on glial scar formation after spinal cord injury in rats J. Neurosurg. Spine 21 2014 966 973
56. T.A. Hamilton, C. Zhao, P.G. Pavicic Jr., and S. Datta Myeloid colony-stimulating factors as regulators of macrophage polarization Front. Immunol. 5 2014 554
57. K. Hayashi, S. Ohta, Y. Kawakami, and M. Toda Activation of dendritic-like cells and neural stem/progenitor cells in injured spinal cord by GM-CSF Neurosci. Res. 64 2009 96 103
58. N. Karin The multiple faces of CXCL12 (SDF-1alpha) in the regulation of immunity during health and disease J. Leukoc. Biol. 88 2010 463 473
59. L. Sanchez-Martin, A. Estecha, R. Samaniego, S. Sanchez-Ramon, M.A. Vega, and P. Sanchez-Mateos The chemokine CXCL12 regulates monocyte-macrophage differentiation and RUNX3 expression Blood 117 2011 88 97
60. A. Didangelos, M. Iberl, E. Vinsland, K. Bartus, and E.J. Bradbury Regulation of IL-10 by chondroitinase ABC promotes a distinct immune response following spinal cord injury J. Neurosci. 34 2014 16424 16432
61. X.C. Ji, Y.Y. Dang, H.Y. Gao, Z.T. Wang, M. Gao, Y. Yang, H.T. Zhang, and R.X. Xu Local Injection of Lenti-BDNF at the Lesion Site Promotes M2 Macrophage Polarization and Inhibits Inflammatory Response After Spinal Cord Injury in Mice Cell. Mol. Neurobiol. 35 2015 881 890
62. S.C. Ghivizzani, E.R. Lechman, R. Kang, C. Tio, J. Kolls, C.H. Evans, and P.D. Robbins Direct adenovirus-mediated gene transfer of interleukin 1 and tumor necrosis factor alpha soluble receptors to rabbit knees with experimental arthritis has local and distal anti-arthritic effects Proc. Natl. Acad. Sci. U. S. A. 95 1998 4613 4618
63. K.S. Goudy, M.C. Johnson, A. Garland, C. Li, R.J. Samulski, B. Wang, and R. Tisch Inducible adeno-associated virus-mediated IL-2 gene therapy prevents autoimmune diabetes J. Immunol. 186 2011 3779 3786
64. E. Butti, A. Bergami, A. Recchia, E. Brambilla, U. Del Carro, S. Amadio, A. Cattalini, M. Esposito, A. Stornaiuolo, G. Comi, S. Pluchino, F. Mavilio, G. Martino, and R. Furlan IL4 gene delivery to the CNS recruits regulatory T cells and induces clinical recovery in mouse models of multiple sclerosis Gene Ther. 15 2008 504 515
65. K. Goudy, S. Song, C. Wasserfall, Y.C. Zhang, M. Kapturczak, A. Muir, M. Powers, M. Scott-Jorgensen, M. Campbell-Thompson, J.M. Crawford, T.M. Ellis, T.R. Flotte, and M.A. Atkinson Adeno-associated virus vector-mediated IL-10 gene delivery prevents type 1 diabetes in NOD mice Proc. Natl. Acad. Sci. U. S. A. 98 2001 13913 13918
66. D.J. Cua, B. Hutchins, D.M. LaFace, S.A. Stohlman, and R.L. Coffman Central nervous system expression of IL-10 inhibits autoimmune encephalomyelitis J. Immunol. 166 2001 602 608
67. R.M. Boehler, R. Kuo, S. Shin, A.G. Goodman, M.A. Pilecki, R.M. Gower, J.N. Leonard, and L.D. Shea Lentivirus delivery of IL-10 to promote and sustain macrophage polarization towards an anti-inflammatory phenotype Biotechnol. Bioeng. 111 2014 1210 1221
68. R.M. Gower, R.M. Boehler, S.M. Azarin, C.F. Ricci, J.N. Leonard, and L.D. Shea Modulation of leukocyte infiltration and phenotype in microporous tissue engineering scaffolds via vector induced IL-10 expression Biomaterials 35 2014 2024 2031
69. H.M. Wilson, S. Chettibi, C. Jobin, D. Walbaum, A.J. Rees, and D.C. Kluth Inhibition of macrophage nuclear factor-kappaB leads to a dominant anti-inflammatory phenotype that attenuates glomerular inflammation in vivo Am. J. Pathol. 167 2005 27 37
70. Z. Su, W. Niu, M.L. Liu, Y. Zou, and C.L. Zhang In vivo conversion of astrocytes to neurons in the injured adult spinal cord Nat. Commun. 5 2014 3338
71. S. Watanabe, K. Uchida, H. Nakajima, H. Matsuo, D. Sugita, A. Yoshida, K. Honjoh, W.E. Johnson, and H. Baba Early transplantation of mesenchymal stem cells after spinal cord injury relieves pain hypersensitivity through suppression of pain-related signaling cascades and reduced inflammatory cell recruitment Stem Cells 33 2015 1902 1914
72. K. English Mechanisms of mesenchymal stromal cell immunomodulation Immunol. Cell Biol. 91 2013 19 26
73. A. Nazmi, I. Mohamed Arif, K. Dutta, K. Kundu, and A. Basu Neural stem/progenitor cells induce conversion of encephalitogenic T cells into CD4 + -CD25 + - FOXP3 + regulatory T cells Viral Immunol. 27 2014 48 59
74. L. Wang, J. Shi, F.W. van Ginkel, L. Lan, G. Niemeyer, D.R. Martin, E.Y. Snyder, and N.R. Cox Neural stem/progenitor cells modulate immune responses by suppressing T lymphocytes with nitric oxide and prostaglandin E2 Exp. Neurol. 216 2009 177 183
75. V. Bonnamain, E. Mathieux, R. Thinard, P. Thebault, V. Nerriere-Daguin, X. Leveque, I. Anegon, B. Vanhove, I. Neveu, and P. Naveilhan Expression of heme oxygenase-1 in neural stem/progenitor cells as a potential mechanism to evade host immune response Stem Cells 30 2012 2342 2353
76. J.G. Graham, X. Zhang, A. Goodman, K. Pothoven, J. Houlihan, S. Wang, R.M. Gower, X. Luo, and L.D. Shea PLG scaffold delivered antigen-specific regulatory T cells induce systemic tolerance in autoimmune diabetes Tissue Eng. A 19 2013 1465 1475
77. N. Marek, A. Krzystyniak, I. Ergenc, O. Cochet, R. Misawa, L.J. Wang, K. Golab, X. Wang, G. Kilimnik, M. Hara, S. Kizilel, P. Trzonkowski, J.M. Millis, and P. Witkowski Coating human pancreatic islets with CD4(+)CD25(high)CD127(-) regulatory T cells as a novel approach for the local immunoprotection Ann. Surg. 254 2011 512 518 (discussion 518-519)
78. H.T. Lau, M. Yu, A. Fontana, and C.J. Stoeckert Jr. Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice Science 273 1996 109 112
79. R.J. Plenter, T.J. Grazia, D.P. Nelson, M.R. Zamora, R.G. Gill, and B.A. Pietra Ectopic expression of Fas Ligand on cardiomyocytes renders cardiac allografts resistant to CD4(+) T-cell mediated rejection Cell. Immunol. 293 2015 30 33
80. M. Pearl-Yafe, E.S. Yolcu, J. Stein, O. Kaplan, I. Yaniv, H. Shirwan, and N. Askenasy Fas ligand enhances hematopoietic cell engraftment through abrogation of alloimmune responses and nonimmunogenic interactions Stem Cells 25 2007 1448 1455
81. W.J. Kao, D. Lee, J.C. Schense, and J.A. Hubbell Fibronectin modulates macrophage adhesion and FBGC formation: the role of RGD, PHSRN, and PRRARV domains J. Biomed. Mater. Res. 55 2001 79 88
82. W.J. Kao, and Y. Liu Utilizing biomimetic oligopeptides to probe fibronectin-integrin binding and signaling in regulating macrophage function in vitro and in vivo Front. Biosci. 6 2001 D992 D999
83. L. Van Parijs, and A.K. Abbas Role of Fas-mediated cell death in the regulation of immune responses Curr. Opin. Immunol. 8 1996 355 361
84. A.N. Ilinskaya, and M.A. Dobrovolskaia Immunosuppressive and anti-inflammatory properties of engineered nanomaterials Br. J. Pharmacol. 171 2014 3988 4000
85. S.P. Zustiak, Y. Wei, and J.B. Leach Protein-hydrogel interactions in tissue engineering: mechanisms and applications Tissue Eng. Part B Rev. 19 2013 160 171
86. H.P. Lim, B.T. Tey, and E.S. Chan Particle designs for the stabilization and controlled-delivery of protein drugs by biopolymers: a case study on insulin J. Control. Release 186 2014 11 21
87. Y. Jiang, J. Chen, C. Deng, E.J. Suuronen, and Z. Zhong Click hydrogels, microgels and nanogels: emerging platforms for drug delivery and tissue engineering Biomaterials 35 2014 4969 4985
88. L. Bischoff, S. Alvarez, D.L. Dai, G. Soukhatcheva, P.C. Orban, and C.B. Verchere Cellular mechanisms of CCL22-mediated attenuation of autoimmune diabetes J. Immunol. 194 2015 3054 3064
89. T. Chen, J. Yuan, S. Duncanson, M.L. Hibert, B.C. Kodish, G. Mylavaganam, M. Maker, H. Li, M. Sremac, M. Santosuosso, B. Forbes, S. Kashiwagi, J. Cao, J. Lei, M. Thomas, C. Hartono, D. Sachs, J. Markmann, A. Sambanis, and M.C. Poznansky Alginate encapsulant incorporating CXCL12 supports long-term allo- and xenoislet transplantation without systemic immune suppression Am. J. Transplant. 15 2015 618 627
90. K. Oshikawa, H. Yamasawa, and Y. Sugiyama Human lung fibroblasts inhibit macrophage inflammatory protein-1alpha production by lipopolysaccharide-stimulated macrophages Biochem. Biophys. Res. Commun. 312 2003 650 655
91. A.S. Chung, and W.J. Kao Fibroblasts regulate monocyte response to ECM-derived matrix: the effects on monocyte adhesion and the production of inflammatory, matrix remodeling, and growth factor proteins J. Biomed. Mater. Res. A 89 2009 841 853
92. A.K. Pannier, and L.D. Shea Controlled release systems for DNA delivery Mol. Ther. 10 2004 19 26
93. D. Bumcrot, M. Manoharan, V. Koteliansky, and D.W. Sah RNAi therapeutics: a potential new class of pharmaceutical drugs Nat. Chem. Biol. 2 2006 711 719
94. C.R. Middaugh, R.K. Evans, D.L. Montgomery, and D.R. Casimiro Analysis of plasmid DNA from a pharmaceutical perspective J. Pharm. Sci. 87 1998 130 146
95. B. Bajaj, P. Lei, and S.T. Andreadis High efficiencies of gene transfer with immobilized recombinant retrovirus: kinetics and optimization Biotechnol. Prog. 17 2001 587 596
96. R.A. Proctor Fibronectin: a brief overview of its structure, function, and physiology Rev. Infect. Dis. 9 Suppl. 4 1987 S317 S321
97. R.J. Levy, C. Song, S. Tallapragada, S. DeFelice, J.T. Hinson, N. Vyavahare, J. Connolly, K. Ryan, and Q. Li Localized adenovirus gene delivery using antiviral IgG complexation Gene Ther. 8 2001 659 667
98. T. Segura, and L.D. Shea Surface-tethered DNA complexes for enhanced gene delivery Bioconjug. Chem. 13 2002 621 629
99. L. De Laporte, and L.D. Shea Matrices and scaffolds for DNA delivery in tissue engineering Adv. Drug Deliv. Rev. 59 2007 292 307
100. C. Holladay, K. Power, M. Sefton, T. O'Brien, W.M. Gallagher, and A. Pandit Functionalized scaffold-mediated interleukin 10 gene delivery significantly improves survival rates of stem cells in vivo Mol. Ther. 19 2011 969 978
101. C.A. Holladay, A.M. Duffy, X. Chen, M.V. Sefton, T.D. O'Brien, and A.S. Pandit Recovery of cardiac function mediated by MSC and interleukin-10 plasmid functionalised scaffold Biomaterials 33 2012 1303 1314
102. M. Drukker Immunogenicity of embryonic stem cells and their progeny Methods Enzymol. 420 2006 391 409
103. M. Drukker, G. Katz, A. Urbach, M. Schuldiner, G. Markel, J. Itskovitz-Eldor, B. Reubinoff, O. Mandelboim, and N. Benvenisty Characterization of the expression of MHC proteins in human embryonic stem cells Proc. Natl. Acad. Sci. U. S. A. 99 2002 9864 9869
104. D.J. Barbeau, K.T. La, D.S. Kim, S.S. Kerpedjieva, G.V. Shurin, and K. Tamama Early growth response-2 signaling mediates immunomodulatory effects of human multipotential stromal cells Stem Cells Dev. 23 2014 155 166
105. T. Gharibi, M. Ahmadi, N. Seyfizadeh, F. Jadidi-Niaragh, and M. Yousefi Immunomodulatory characteristics of mesenchymal stem cells and their role in the treatment of multiple sclerosis Cell. Immunol. 293 2015 113 121
106. M.S. Kwon, M.Y. Noh, K.W. Oh, K.A. Cho, B.Y. Kang, K.S. Kim, Y.S. Kim, and S.H. Kim The immunomodulatory effects of human mesenchymal stem cells on peripheral blood mononuclear cells in ALS patients J. Neurochem. 131 2014 206 218
107. P. Luz-Crawford, M. Kurte, J. Bravo-Alegria, R. Contreras, E. Nova-Lamperti, G. Tejedor, D. Noel, C. Jorgensen, F. Figueroa, F. Djouad, and F. Carrion Mesenchymal stem cells generate a CD4 + CD25 + Foxp3 + regulatory T cell population during the differentiation process of Th1 and Th17 cells Stem Cell Res. Ther. 4 2013 65
108. N. Obermajer, F.C. Popp, Y. Soeder, J. Haarer, E.K. Geissler, H.J. Schlitt, and M.H. Dahlke Conversion of Th17 into IL-17A(neg) regulatory T cells: a novel mechanism in prolonged allograft survival promoted by mesenchymal stem cell-supported minimized immunosuppressive therapy J. Immunol. 193 2014 4988 4999
109. Z. Yan, Y. Zhuansun, R. Chen, J. Li, and P. Ran Immunomodulation of mesenchymal stromal cells on regulatory T cells and its possible mechanism Exp. Cell Res. 324 2014 65 74
110. L. Gao, Q. Lu, L.J. Huang, L.H. Ruan, J.J. Yang, W.L. Huang, W.S. ZhuGe, Y.L. Zhang, B. Fu, K.L. Jin, and Q.C. ZhuGe Transplanted neural stem cells modulate regulatory T, gammadelta T cells and corresponding cytokines after intracerebral hemorrhage in rats Int. J. Mol. Sci. 15 2014 4431 4441
111. M. Francois, R. Romieu-Mourez, M. Li, and J. Galipeau Human MSC suppression correlates with cytokine induction of indoleamine 2,3-dioxygenase and bystander M2 macrophage differentiation Mol. Ther. 20 2012 187 195
112. J. Liu, C. Gotherstrom, M. Forsberg, E.B. Samuelsson, J. Wu, C. Calzarossa, O. Hovatta, E. Sundstrom, and E. Akesson Human neural stem/progenitor cells derived from embryonic stem cells and fetal nervous system present differences in immunogenicity and immunomodulatory potentials in vitro Stem Cell Res. 10 2013 325 337
113. J.L. Reading, J.H. Yang, S. Sabbah, A. Skowera, R.R. Knight, J. Pinxteren, B. Vaes, T. Allsopp, A.E. Ting, S. Busch, A. Raber, R. Deans, and T.I. Tree Clinical-grade multipotent adult progenitor cells durably control pathogenic T cell responses in human models of transplantation and autoimmunity J. Immunol. 190 2013 4542 4552
114. A. Uccelli, L. Moretta, and V. Pistoia Mesenchymal stem cells in health and disease Nat. Rev. Immunol. 8 2008 726 736
115. J. Galipeau The mesenchymal stromal cells dilemma - does a negative phase III trial of random donor mesenchymal stromal cells in steroid-resistant graft-versus-host disease represent a death knell or a bump in the road? Cytotherapy 15 2013 2 8
116. R. Melzi, B. Antonioli, A. Mercalli, M. Battaglia, A. Valle, S. Pluchino, R. Galli, V. Sordi, E. Bosi, G. Martino, E. Bonifacio, C. Doglioni, and L. Piemonti Co-graft of allogeneic immune regulatory neural stem cells (NPC) and pancreatic islets mediates tolerance, while inducing NPC-derived tumors in mice PLoS One 5 2010 e10357
117. Y. Ding, D. Xu, G. Feng, A. Bushell, R.J. Muschel, and K.J. Wood Mesenchymal stem cells prevent the rejection of fully allogenic islet grafts by the immunosuppressive activity of matrix metalloproteinase-2 and - 9 Diabetes 58 2009 1797 1806
118. M. Caridade, L. Graca, and R.M. Ribeiro Mechanisms Underlying CD4 + Treg Immune Regulation in the Adult: From Experiments to Models Front. Immunol. 4 2013 378
119. E.S. Yolcu, H. Zhao, L. Bandura-Morgan, C. Lacelle, K.B. Woodward, N. Askenasy, and H. Shirwan Pancreatic islets engineered with SA-FasL protein establish robust localized tolerance by inducing regulatory T cells in mice J. Immunol. 187 2011 5901 5909
120. J.M. Schwab, Y. Zhang, M.A. Kopp, B. Brommer, and P.G. Popovich The paradox of chronic neuroinflammation, systemic immune suppression, autoimmunity after traumatic chronic spinal cord injury Exp. Neurol. 258 2014 121 129
121. K. Kil, Y.C. Zang, D. Yang, J. Markowski, G.S. Fuoco, G.C. Vendetti, V.M. Rivera, and J.Z. Zhang T cell responses to myelin basic protein in patients with spinal cord injury and multiple sclerosis J. Neuroimmunol. 98 1999 201 207
122. A. Ibarra, A. Jimenez, C. Cortes, and D. Correa Influence of the intensity, level and phase of spinal cord injury on the proliferation of T cells and T-cell-dependent antibody reactions in rats Spinal Cord 45 2007 380 386
123. J.S. Bromberg, W.F. Fricke, C.C. Brinkman, T. Simon, and E.F. Mongodin Microbiota-implications for immunity and transplantation Nat. Rev. Nephrol. 11 2015 342 353
124. J.C. Fleming, F. Bao, Y. Chen, E.F. Hamilton, J.K. Relton, and L.C. Weaver Alpha4beta1 integrin blockade after spinal cord injury decreases damage and improves neurological function Exp. Neurol. 214 2008 147 159
125. L.M. Howard, A.J. Miga, C.L. Vanderlugt, M.C. Dal Canto, J.D. Laman, R.J. Noelle, and S.D. Miller Mechanisms of immunotherapeutic intervention by anti-CD40L (CD154) antibody in an animal model of multiple sclerosis J. Clin. Invest. 103 1999 281 290
126. S.H. Im, D. Barchan, P.K. Maiti, S. Fuchs, and M.C. Souroujon Blockade of CD40 ligand suppresses chronic experimental myasthenia gravis by down-regulation of Th1 differentiation and up-regulation of CTLA-4 J. Immunol. 166 2001 6893 6898
127. R. Gonzalez, J. Glaser, M.T. Liu, T.E. Lane, and H.S. Keirstead Reducing inflammation decreases secondary degeneration and functional deficit after spinal cord injury Exp. Neurol. 184 2003 456 463
128. A.R. Guerrero, K. Uchida, H. Nakajima, S. Watanabe, M. Nakamura, W.E. Johnson, and H. Baba Blockade of interleukin-6 signaling inhibits the classic pathway and promotes an alternative pathway of macrophage activation after spinal cord injury in mice J. Neuroinflammation 9 2012 40
129. S.H. Im, D. Barchan, P.K. Maiti, L. Raveh, M.C. Souroujon, and S. Fuchs Suppression of experimental myasthenia gravis, a B cell-mediated autoimmune disease, by blockade of IL-18 FASEB J. 15 2001 2140 2148
130. E. Israel-Assayag, M. Fournier, and Y. Cormier Blockade of T cell costimulation by CTLA4-Ig inhibits lung inflammation in murine hypersensitivity pneumonitis J. Immunol. 163 1999 6794 6799
131. A. Tang, T.A. Judge, B.J. Nickoloff, and L.A. Turka Suppression of murine allergic contact dermatitis by CTLA4Ig. Tolerance induction of Th2 responses requires additional blockade of CD40-ligand J. Immunol. 157 1996 117 125
132. M. Meister, M. Papatriantafyllou, V. Nordstrom, V. Kumar, J. Ludwig, K.O. Lui, A.S. Boyd, Z.V. Popovic, T.H. Fleming, G. Moldenhauer, P.P. Nawroth, H.J. Grone, H. Waldmann, T. Oelert, and B. Arnold Dickkopf-3, a tissue-derived modulator of local T-cell responses Front. Immunol. 6 2015 78
133. R. Yuan, Y. Maeda, W. Li, W. Lu, S. Cook, and P. Dowling Erythropoietin: a potent inducer of peripheral immuno/inflammatory modulation in autoimmune EAE PLoS One 3 2008 e1924
134. H. Chu, Y. Tang, and Q. Dong Protection of granulocyte-colony stimulating factor to hemorrhagic brain injuries and its involved mechanisms: effects of vascular endothelial growth factor and aquaporin-4 Neuroscience 260 2014 59 72
135. M. Rossetti, S. Gregori, and M.G. Roncarolo Granulocyte-colony stimulating factor drives the in vitro differentiation of human dendritic cells that induce anergy in naive T cells Eur. J. Immunol. 40 2010 3097 3106
136. I.I. Muller, M. Chatterjee, M. Schneider, O. Borst, P. Seizer, T. Schonberger, S. Vogel, K.A. Muller, T. Geisler, F. Lang, H. Langer, and M. Gawaz Gremlin-1 inhibits macrophage migration inhibitory factor-dependent monocyte function and survival Int. J. Cardiol. 176 2014 923 929
137. M. Benkhoucha, M.L. Santiago-Raber, G. Schneiter, M. Chofflon, H. Funakoshi, T. Nakamura, and P.H. Lalive Hepatocyte growth factor inhibits CNS autoimmunity by inducing tolerogenic dendritic cells and CD25 + Foxp3 + regulatory T cells Proc. Natl. Acad. Sci. U. S. A. 107 2010 6424 6429
138. J. Liu, X. Zhou, Z. Zhan, Q. Meng, Y. Han, Q. Shi, J. Tang, J. Li, H. Fan, and Z. Liu IL-25 regulates the polarization of macrophages and attenuates obliterative bronchiolitis in murine trachea transplantation models Int. Immunopharmacol. 25 2015 383 392
139. J.C. Alves-Filho, F. Sonego, F.O. Souto, A. Freitas, W.A. Verri Jr., M. Auxiliadora-Martins, A. Basile-Filho, A.N. McKenzie, D. Xu, F.Q. Cunha, and F.Y. Liew Interleukin-33 attenuates sepsis by enhancing neutrophil influx to the site of infection Nat. Med. 16 2010 708 712
140. S.P. Gadani, J.T. Walsh, I. Smirnov, J. Zheng, and J. Kipnis The Glia-Derived Alarmin IL-33 Orchestrates the Immune Response and Promotes Recovery following CNS Injury Neuron 85 2015 703 709
141. B.M. Matta, J.M. Lott, L.R. Mathews, Q. Liu, B.R. Rosborough, B.R. Blazar, and H.R. Turnquist IL-33 is an unconventional Alarmin that stimulates IL-2 secretion by dendritic cells to selectively expand IL-33R/ST2 + regulatory T cells J. Immunol. 193 2014 4010 4020
142. Y. Pomeshchik, I. Kidin, P. Korhonen, E. Savchenko, M. Jaronen, S. Lehtonen, S. Wojciechowski, K. Kanninen, J. Koistinaho, and T. Malm Interleukin-33 treatment reduces secondary injury and improves functional recovery after contusion spinal cord injury Brain Behav. Immun. 44 2015 68 81
143. I. Ifergan, K. Wosik, R. Cayrol, H. Kebir, C. Auger, M. Bernard, A. Bouthillier, R. Moumdjian, P. Duquette, and A. Prat Statins reduce human blood-brain barrier permeability and restrict leukocyte migration: relevance to multiple sclerosis Ann. Neurol. 60 2006 45 55
144. F. Casiraghi, N. Azzollini, M. Todeschini, R.A. Cavinato, P. Cassis, S. Solini, C. Rota, M. Morigi, M. Introna, R. Maranta, N. Perico, G. Remuzzi, and M. Noris Localization of mesenchymal stromal cells dictates their immune or proinflammatory effects in kidney transplantation Am. J. Transplant. 12 2012 2373 2383
145. N. Zhang, B. Schroppel, G. Lal, C. Jakubzick, X. Mao, D. Chen, N. Yin, R. Jessberger, J.C. Ochando, Y. Ding, and J.S. Bromberg Regulatory T cells sequentially migrate from inflamed tissues to draining lymph nodes to suppress the alloimmune response Immunity 30 2009 458 469
146. M.C. Baas, C. Kuhn, F. Valette, C. Mangez, M.S. Duarte, M. Hill, A. Besancon, L. Chatenoud, M.C. Cuturi, and S. You Combining autologous dendritic cell therapy with CD3 antibodies promotes regulatory T cells and permanent islet allograft acceptance J. Immunol. 193 2014 4696 4703
147. J. Bryant, N.M. Lerret, J.J. Wang, H.K. Kang, J. Tasch, Z. Zhang, and X. Luo Preemptive donor apoptotic cell infusions induce IFN-gamma-producing myeloid-derived suppressor cells for cardiac allograft protection J. Immunol. 192 2014 6092 6101
148. T. Kheradmand, S. Wang, J. Bryant, J.J. Tasch, N. Lerret, K.L. Pothoven, J.L. Houlihan, S.D. Miller, Z.J. Zhang, and X. Luo Ethylenecarbodiimide-fixed donor splenocyte infusions differentially target direct and indirect pathways of allorecognition for induction of transplant tolerance J. Immunol. 189 2012 804 812
149. S. Wang, X. Zhang, L. Zhang, J. Bryant, T. Kheradmand, B.J. Hering, S.D. Miller, and X. Luo Preemptive Tolerogenic Delivery of Donor Antigens for Permanent Allogeneic Islet Graft Protection Cell Transplant. 24 2014 1155 1165
150. D.R. Getts, D.M. Turley, C.E. Smith, C.T. Harp, D. McCarthy, E.M. Feeney, M.T. Getts, A.J. Martin, X. Luo, R.L. Terry, N.J. King, and S.D. Miller Tolerance induced by apoptotic antigen-coupled leukocytes is induced by PD-L1 + and IL-10-producing splenic macrophages and maintained by T regulatory cells J. Immunol. 187 2011 2405 2417
151. X. Luo, K.L. Pothoven, D. McCarthy, M. DeGutes, A. Martin, D.R. Getts, G. Xia, J. He, X. Zhang, D.B. Kaufman, and S.D. Miller ECDI-fixed allogeneic splenocytes induce donor-specific tolerance for long-term survival of islet transplants via two distinct mechanisms Proc. Natl. Acad. Sci. U. S. A. 105 2008 14527 14532
152. S. Kontos, I.C. Kourtis, K.Y. Dane, and J.A. Hubbell Engineering antigens for in situ erythrocyte binding induces T-cell deletion Proc. Natl. Acad. Sci. U. S. A. 110 2013 E60 E68
153. D.R. Getts, R.L. Terry, M.T. Getts, C. Deffrasnes, M. Muller, C. van Vreden, T.M. Ashhurst, B. Chami, D. McCarthy, H. Wu, J. Ma, A. Martin, L.D. Shae, P. Witting, G.S. Kansas, J. Kuhn, W. Hafezi, I.L. Campbell, D. Reilly, J. Say, L. Brown, M.Y. White, S.J. Cordwell, S.J. Chadban, E.B. Thorp, S. Bao, S.D. Miller, and N.J. King Therapeutic inflammatory monocyte modulation using immune-modifying microparticles Sci. Transl. Med. 6 2014 219ra217
154. D.R.K. Getts, and N.J. King Immune-Modifying Particles for the Treatment of Inflammation 2013 Cour Pharmaceutical Development Company United States
155. D.R. Getts, A.J. Martin, D.P. McCarthy, R.L. Terry, Z.H. Hunter, W.T. Yap, M.T. Getts, M. Pleiss, X. Luo, N.J.C. King, L.D. Shea, and S.D. Miller Microparticles bearing encephalitogenic peptides induce T-cell tolerance and ameliorate experimental autoimmune encephalomyelitis Nat. Biotechnol. 30 2012 1217 1224
156. S. Kanno, A. Furuyama, and S. Hirano A murine scavenger receptor MARCO recognizes polystyrene nanoparticles Toxicol. Sci. 97 2007 398 406
157. R.A. Maldonado, R.A. LaMothe, J.D. Ferrari, A.H. Zhang, R.J. Rossi, P.N. Kolte, A.P. Griset, C. O'Neil, D.H. Altreuter, E. Browning, L. Johnston, O.C. Farokhzad, R. Langer, D.W. Scott, U.H. von Andrian, and T.K. Kishimoto Polymeric synthetic nanoparticles for the induction of antigen-specific immunological tolerance Proc. Natl. Acad. Sci. U. S. A. 112 2015 E156 E165
158. D.R. Getts Editorial to special issue: monocytes in homeostasis and disease Cell. Immunol. 291 2014 1 2
159. D.R. Getts, R.L. Terry, M.T. Getts, M. Muller, S. Rana, B. Shrestha, J. Radford, N. Van Rooijen, I.L. Campbell, and N.J. King Ly6c + "inflammatory monocytes" are microglial precursors recruited in a pathogenic manner in West Nile virus encephalitis J. Exp. Med. 205 2008 2319 2337
160. D.R. Getts, R.L. Terry, M.T. Getts, M. Muller, S. Rana, C. Deffrasnes, T.M. Ashhurst, J. Radford, M. Hofer, S. Thomas, I.L. Campbell, and N.J. King Targeted blockade in lethal West Nile virus encephalitis indicates a crucial role for very late antigen (VLA)-4-dependent recruitment of nitric oxide-producing macrophages J. Neuroinflammation 9 2012 246
161. M.D. Majmudar, E.J. Keliher, T. Heidt, F. Leuschner, J. Truelove, B.F. Sena, R. Gorbatov, Y. Iwamoto, P. Dutta, G. Wojtkiewicz, G. Courties, M. Sebas, A. Borodovsky, K. Fitzgerald, M.W. Nolte, G. Dickneite, J.W. Chen, D.G. Anderson, F.K. Swirski, R. Weissleder, and M. Nahrendorf Monocyte-directed RNAi targeting CCR2 improves infarct healing in atherosclerosis-prone mice Circulation 127 2013 2038 2046
162. T. Saxena, K.H. Loomis, S.B. Pai, L. Karumbaiah, E. Gaupp, K. Patil, R. Patkar, and R.V. Bellamkonda Nanocarrier-mediated inhibition of macrophage migration inhibitory factor attenuates secondary injury after spinal cord injury ACS Nano 9 2015 1492 1505
163. M. Fransson, E. Piras, J. Burman, B. Nilsson, M. Essand, B. Lu, R.A. Harris, P.U. Magnusson, E. Brittebo, and A.S. Loskog CAR/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery J. Neuroinflammation 9 2012 112
164. K.G. Haanstra, K. Dijkman, N. Bashir, J. Bauer, C. Mary, N. Poirier, P. Baker, L. Scobie, B.A. t Hart, and B. Vanhove Selective blockade of CD28-mediated T cell costimulation protects rhesus monkeys against acute fatal experimental autoimmune encephalomyelitis J. Immunol. 194 2015 1454 1466
165. G.L. Szot, M. Yadav, J. Lang, E. Kroon, J. Kerr, K. Kadoya, E.P. Brandon, E.E. Baetge, H. Bour-Jordan, and J.A. Bluestone Tolerance induction and reversal of diabetes in mice transplanted with human embryonic stem cell-derived pancreatic endoderm Cell Stem Cell 16 2015 148 157
166. S.J. Krinzman, G.T. De Sanctis, M. Cernadas, D. Mark, Y. Wang, J. Listman, L. Kobzik, C. Donovan, K. Nassr, I. Katona, D.C. Christiani, D.L. Perkins, and P.W. Finn Inhibition of T cell costimulation abrogates airway hyperresponsiveness in a murine model J. Clin. Invest. 98 1996 2693 2699
167. T. Kheradmand, S. Wang, R.F. Gibly, X. Zhang, S. Holland, J. Tasch, J.G. Graham, D.B. Kaufman, S.D. Miller, L.D. Shea, and X. Luo Permanent protection of PLG scaffold transplanted allogeneic islet grafts in diabetic mice treated with ECDI-fixed donor splenocyte infusions Biomaterials 32 2011 4517 4524
168. S. Wang, J. Tasch, T. Kheradmand, J. Ulaszek, S. Ely, X. Zhang, B.J. Hering, S.D. Miller, and X. Luo Transient B-cell depletion combined with apoptotic donor splenocytes induces xeno-specific T- and B-cell tolerance to islet xenografts Diabetes 62 2013 3143 3150
169. G. Chen, T. Kheradmand, J. Bryant, S. Wang, J. Tasch, J.J. Wang, Z. Zhang, and X. Luo Intragraft CD11b(+) IDO(+) cells mediate cardiac allograft tolerance by ECDI-fixed donor splenocyte infusions Am. J. Transplant. 12 2012 2920 2929
170. R.E. Hoeppli, D. Wu, L. Cook, and M.K. Levings The environment of regulatory T cell biology: cytokines, metabolites, and the microbiome Front. Immunol. 6 2015 61
171. J.R. Podojil, and S.D. Miller Molecular mechanisms of T-cell receptor and costimulatory molecule ligation/blockade in autoimmune disease therapy Immunol. Rev. 229 2009 337 355
172. S. Prasad, A.P. Kohm, J.S. McMahon, X. Luo, and S.D. Miller Pathogenesis of NOD diabetes is initiated by reactivity to the insulin B chain 9-23 epitope and involves functional epitope spreading J. Autoimmun. 39 2012 347 353
173. A. Lutterotti, S. Yousef, A. Sputtek, K.H. Sturner, J.P. Stellmann, P. Breiden, S. Reinhardt, C. Schulze, M. Bester, C. Heesen, S. Schippling, S.D. Miller, M. Sospedra, and R. Martin Antigen-specific tolerance by autologous myelin peptide-coupled cells: a phase 1 trial in multiple sclerosis Sci. Transl. Med. 5 2013 188ra175
174. D. Wang, H. Zhang, J. Liang, X. Li, X. Feng, H. Wang, B. Hua, B. Liu, L. Lu, G.S. Gilkeson, R.M. Silver, W. Chen, S. Shi, and L. Sun Allogeneic mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus: 4 years of experience Cell Transplant. 22 2013 2267 2277
175. G.M. Forbes, M.J. Sturm, R.W. Leong, M.P. Sparrow, D. Segarajasingam, A.G. Cummins, M. Phillips, and R.P. Herrmann A phase 2 study of allogeneic mesenchymal stromal cells for luminal Crohn's disease refractory to biologic therapy Clin. Gastroenterol. Hepatol. 12 2014 64 71
176. Z. Hunter, D.P. McCarthy, W.T. Yap, C.T. Harp, D.R. Getts, L.D. Shea, and S.D. Miller A biodegradable nanoparticle platform for the induction of antigen-specific immune tolerance for treatment of autoimmune disease ACS Nano 8 2014 2148 2160
177. L. Agemy, K.N. Sugahara, V.R. Kotamraju, K. Gujraty, O.M. Girard, Y. Kono, R.F. Mattrey, J.H. Park, M.J. Sailor, A.I. Jimenez, C. Cativiela, D. Zanuy, F.J. Sayago, C. Aleman, R. Nussinov, and E. Ruoslahti Nanoparticle-induced vascular blockade in human prostate cancer Blood 116 2010 2847 2856
178. L. Gu, L.E. Ruff, Z. Qin, M. Corr, S.M. Hedrick, and M.J. Sailor Multivalent porous silicon nanoparticles enhance the immune activation potency of agonistic CD40 antibody Adv. Mater. 24 2012 3981 3987
179. G. von Maltzahn, J.H. Park, K.Y. Lin, N. Singh, C. Schwoppe, R. Mesters, W.E. Berdel, E. Ruoslahti, M.J. Sailor, and S.N. Bhatia Nanoparticles that communicate in vivo to amplify tumour targeting Nat. Mater. 10 2011 545 552